Methylprednisolone administered before cardiopulmonary bypass significantly reduced the production of proinflammatory cytokines IL-6 and IL-8 compared to control (p<0.01 for both).
RCT (n=21)
Open-label
Randomized sequence
No
Does methylprednisolone improve cytokine balance in patients undergoing aortocoronary bypass surgery?
Methylprednisolone administration during cardiopulmonary bypass reduces proinflammatory cytokine production without affecting anti-inflammatory cytokines, suggesting a cytoprotective mechanism.
p-value: p=<.01
Objective To determine the influence of methylprednisolone on the cytokine balance during cardiac surgery. Design Prospective, randomized, nonblinded study. Setting University hospital. Patients Twenty-one patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Interventions According to a randomized sequence, the patients either received methylprednisolone (30 micro signg/kg) before cardiopulmonary bypass and before declamping of the aorta (MPS group, n = 11) or received nothing (control group, n = 10). Measurements and Main Results Serum proinflammatory cytokines (interleukin IL-8, IL-6) and anti-inflammatory cytokines (IL-10, IL-1ra) were measured by enzyme-linked immunosorbent assays. Serum IL-6 and IL-8 concentrations in the control group (15.2 +/- 4.1 and 14.1 +/- 1.9 pg/mL, preoperatively) increased to 242 +/- 70.1 and 97.3 +/- 18.3 pg/mL at 60 mins after declamping of the aorta (p < .01, p < .01, respectively). The increases were greater than those from 2.5 +/- 0.6 and 2.5 +/- 0.5 pg/mL to 109.5 +/- 29.0 and 33 +/- 4.1 pg/mL in the MPS group for IL-6 and IL-8, respectively. Serum IL-10 concentrations increased significantly 60 mins after declamping of the aorta compared with its preoperative value in the two groups (the control group, from 1.0 +/- 0 to 537.9 +/- 61.7 pg/mL; the MPS group, from 0.3 +/- 0.2 to 654.9 +/- 24 pg/mL p < .01, p < .01, respectively). No difference was found between the two groups. Similarly, serum IL-1ra concentrations in the two groups increased the preoperative value in the control group from 304 +/- 120 to 44,374 +/- 14,631 pg/mL and in the MPS group from 616.5 +/- 109.6 to 35,598 +/- 9,074 pg/mL at 60 mins after declamping of the aorta (p < .01, p < .01, respectively). There was no difference between the two groups. Conclusions Methylprednisolone reduces the production of IL-6 and IL-8 but not that of IL-10 and IL-1ra. These results suggest that one of the mechanisms of the cytoprotective effect of methylprednisolone may be to make changes in the proinflammatory and anti-inflammatory cytokine balance. (Crit Care Med 1999; 27:545-548)
Kawamura et al. (Mon,) conducted a rct in Patients undergoing aortocoronary bypass surgery (n=21). Methylprednisolone vs. Nothing (control) was evaluated on Serum proinflammatory (IL-6, IL-8) and anti-inflammatory (IL-10, IL-1ra) cytokines (p=<.01). Methylprednisolone administered before cardiopulmonary bypass significantly reduced the production of proinflammatory cytokines IL-6 and IL-8 compared to control (p<0.01 for both).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: